跳至主要内容
临床试验/NCT03082196
NCT03082196已完成2 期

Phase 2 Efficacy Evaluation Of Advantage Anti-Caries Varnish

Advantage Dental Services, LLC1 个研究点 分布在 1 个国家目标入组 284 人开始时间: 2017年3月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
284
试验地点
1
主要终点
Dental Caries for All Primary Teeth Sound at Baseline

研究概览

简要总结

The purpose of the study is to determine the efficacy of Advantage Anti-Caries Varnish. Single-center, double-blind, controlled Phase 2 study with parallel groups of children. Subjects will be stratified by early childhood education center and then randomized to receive either test varnish or control varnish topically to the teeth. Treatment will be administered quarterly for up to 24 months. The primary outcome is surface-level primary molar caries increment (d2-4mfs) at 24- months post baseline.

详细描述

Objectives:

Primary

  • To determine if Advantage Anti-Caries Varnish (test varnish) is superior to a control varnish containing only fluoride in the prevention of new caries lesions.

Secondary

  • To establish that the response of child participants to the test varnish was not inferior to the control varnish

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

All study personnel except for designated personnel in the data center will be blinded to the participant treatment assignment. In order to maintain blinding, the caries scoring examinations will precede the application of test varnishes at baseline. The staff member applying these varnishes will not perform the caries scoring exams in order to eliminate examiner bias and ensure blinding to treatment assignment. Test drug and comparator are packaged identically.

入排标准

年龄范围
60 Months 至 84 Months(Child)
性别
All
接受健康志愿者

入选标准

  • The subject's parent or legal guardian must provide signed and dated informed consent (parent permission form).
  • The subject's parent or legal guardian of the subject must be willing and able to comply with study requirements.
  • The subject is aged 60-84 months at the time of enrollment.
  • The subject must be in good general health as evidenced by parent report.

排除标准

  • Known allergy to iodine
  • Known allergy to seafood
  • Known hypersensitivity to fluoride varnish
  • Diagnosis of thyroid disease
  • Chronic, prophylactic use of antibiotics
  • Treatment with another investigational drug or other intervention within 30 days preceding the Baseline Visit.

研究组 & 干预措施

Test varnish

Experimental

Advantage Anti-Caries Varnish. The active ingredients are Povidone Iodine and Sodium Fluoride .

干预措施: Test varnish (Drug)

Standard varnish

Active Comparator

The active control varnish will be the same fluoride varnish without iodine with an appropriate FDA approved food dye added to match the color of the test agent. There will be no difference in the treatment and control varnishes except for the povidone iodine.

干预措施: Standard varnish (Drug)

结局指标

主要结局

Dental Caries for All Primary Teeth Sound at Baseline

时间窗: 24 months

The outcome will be the surface-level primary tooth caries increment (d2-4mfs) at two years post baseline that were sound at baseline. Caries, as measured by d2-4mfs, is the total number of surfaces with decay into the enamel (2), dentin (3) or pulp (4), missing due to caries (m), or filled with amalgam, composite or other filling material (f). This scale records whether caries is detected in any of the 4 or 5 surfaces of the tooth for up to 20 primary teeth that were sound at baseline, and has a range of 0 to 88. Higher values indicate a greater number of caries. The measure records whether caries is present on any of the 5 surfaces of the primary molars or 4 surfaces of the other teeth.

Dental Caries for Primary Molars Sound at Baseline

时间窗: 24 months

The primary outcome will be the surface-level primary molar caries increment (d2-4mfs) at two years post baseline. Caries, as measured by d2-4mfs, is the total number of surfaces with decay into the enamel (2), dentin (3) or pulp (4), missing due to caries (m), or filled with amalgam, composite or other filling material (f). This scale records whether caries is detected in any of the 5 surfaces of the tooth for up to 8 primary molar teeth that were sound at baseline, and has a range of 0 to 40. Higher values indicate a greater number of caries.

次要结局

  • Child Response to Fifth Treatment(After fifth treatment visit)
  • Child Response to First Treatment(After first treatment visit)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

已完成
2 期
Efficacy and Safety Evaluation of Anti-Caries VarnishDental Caries in Children
NCT04947527Advantage Silver Dental Arrest, LLC274
进行中(未招募)
1 期
A phase II study investigating the efficacy and safety of Vvax001, a therapeutic cancer vaccine, in patients with premalignant cervical lesions.
EUCTR2019-004050-29-NLniversity Medical Center Groningen18
招募中
2 期
A phase II study to determine the efficacy and safety of Vvax001, a therapeutic Semliki Forest Virus based cancer vaccine, in patients with HPV-16 induced grade 3 cervical intraepithelial neoplasia.
NL-OMON55191niversitair Medisch Centrum Groningen18
进行中(未招募)
1 期
A study to investigate the protective effects of Glucagon­like Peptide­1 (GLP-­1) in patients undergoing elective angioplasty and stenting.To determine whether an infusion of GLP­1 can reduce the occurrence of myocyte necrosis and infarction caused by percutaneous coronary interventionMedDRA version: 18.0Level: PTClassification code 10066592Term: Post procedural myocardial infarctionSystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsMedDRA version: 18.0Level: LLTClassification code 10002380Term: Angina of effortSystem Organ Class: 100000004849
EUCTR2013-001967-22-GBPapworth Hospital NHS Foundation Trust400
进行中(未招募)
1 期
A Phase II Study to determine the efficacy and safety of conventional dose oral Treosulfan in patients with advanced pre-treated Ewing’s Sarcoma - OTIS
EUCTR2005-003254-10-GBniversity College London25